At a glance
- Originator Akzo Nobel
- Class Anti-ischaemics; Heart failure therapies; Pyrrolidines; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders
Most Recent Events
- 29 Nov 1995 Discontinued-I for Ischaemic heart disorders in France (Unknown route)
- 29 Nov 1995 Discontinued-I for Ischaemic heart disorders in Netherlands (Unknown route)